INTERNATIONAL PATENT: TOPMUNNITY THERAPEUTICS TAIWAN LIMITED FILES APPLICATION FOR "CHIMERIC ANTIGEN RECEPTOR AGAINST PROGRAMMED DEATHLIGAND 1 (PD-L1) AND APPLICATION THEREOF"

GENEVA, Sept. 19 -- TOPMUNNITY THERAPEUTICS TAIWAN LIMITED (2F., No. 99, Ln. 130, Sec. 1, Academia Rd., Nangang Dist., Taipei CityTaiwan 115202) filed a patent application (PCT/CN2024/081655) for "CHIMERIC ANTIGEN RECEPTOR AGAINST PROGRAMMED DEATHLIGAND 1 (PD-L1) AND APPLICATION THEREOF" on Mar 14, 2024. With publication no. WO/2025/189420, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Jyun (2F., No. 14, Aly. 21, Ln. 70, Sec. 6, Zhongxiao E. Rd., Nangang Dist., Taipei CityTaiwan 115025), HUANG, Chao-Yua (4F, No. 3...